The Cardiac Exchange Transistor (https://transistor.fm) https://feeds.transistor.fm/covid-and-cardiac-surgery-where-are-we-now-segment-1 A podcast series from Medtronic that goes straight to your ears to your heart. Join cardiac surgery professionals as they discuss recent developments in patient care, advancements in therapy technology and share personal experiences. © 2023 Medtronic. All Rights Reserved. e723eb31-3e52-54d1-bd46-43d0a1deb39a no en Wed, 24 Sep 2025 21:43:35 -0500 Tue, 02 Dec 2025 17:03:25 -0600 http://Medtronic.com/cardiacexchange https://img.transistor.fm/5Gc6U9RpBiIWwX9nZHVdTEYBdXPrMiBpq2dTy0Fm0oA/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzIzMzMzLzE2MzA1/MTM0OTgtYXJ0d29y/ay5qcGc.jpg The Cardiac Exchange http://Medtronic.com/cardiacexchange episodic Medtronic A podcast series from Medtronic that goes straight to your ears to your heart. Join cardiac surgery professionals as they discuss recent developments in patient care, advancements in therapy technology and share personal experiences. A podcast series from Medtronic that goes straight to your ears to your heart. Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery Katharine Larson No No Durability and Lifetime Management of the Avalus™ Platform 45 45 Durability and Lifetime Management of the Avalus™ Platform full d4ea9988-bf70-4ae8-837d-267c95f57239 https://share.transistor.fm/s/97f818e1 Professor Kappetein sits down with Mr Dincer Aktuerk of Barts Heart Center in London, United Kingdom and Professor Robert Klautz of Leiden University Medical Center, Netherlands to discuss the clinical data from the PERIGON Study. This discussion covers a variety of topics including the importance of data when treating patients, with a focus on lifetime management and durability of surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) surgeries.1

  • 1. Sabik JF III, Rao V, Dagenais F, et al. 7-Year outcomes after surgical aortic valve replacement with a stented bovine pericardial bioprosthesis in over 1100 patients: a prospective multicenter analysis. Eur J Cardiothorac Surg. 2024;67(1):ezae414. doi:10.1093/ejcts/ezae414.

Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic.


See Avalus™ Bioprosthesis risk information: https://www.medtronic.com/en-us/healthcare-professionals/products/cardiovascular/heart-valves/tissue-valves-conduits/avalus-bioprosthesis.html?sheet=open 

]]> Professor Kappetein sits down with Mr Dincer Aktuerk of Barts Heart Center in London, United Kingdom and Professor Robert Klautz of Leiden University Medical Center, Netherlands to discuss the clinical data from the PERIGON Study. This discussion covers a variety of topics including the importance of data when treating patients, with a focus on lifetime management and durability of surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) surgeries.1

  • 1. Sabik JF III, Rao V, Dagenais F, et al. 7-Year outcomes after surgical aortic valve replacement with a stented bovine pericardial bioprosthesis in over 1100 patients: a prospective multicenter analysis. Eur J Cardiothorac Surg. 2024;67(1):ezae414. doi:10.1093/ejcts/ezae414.

Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic.


See Avalus™ Bioprosthesis risk information: https://www.medtronic.com/en-us/healthcare-professionals/products/cardiovascular/heart-valves/tissue-valves-conduits/avalus-bioprosthesis.html?sheet=open 

]]> Wed, 24 Sep 2025 21:42:59 -0500 Medtronic Medtronic 2734 Professor Kappetein sits down with Mr Dincer Aktuerk of Barts Heart Center in London, United Kingdom and Professor Robert Klautz of Leiden University Medical Center, Netherlands to discuss the clinical data from the PERIGON Study. This discussion covers a variety of topics including the importance of data when treating patients, with a focus on lifetime management and durability of surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) surgeries.1

  • 1. Sabik JF III, Rao V, Dagenais F, et al. 7-Year outcomes after surgical aortic valve replacement with a stented bovine pericardial bioprosthesis in over 1100 patients: a prospective multicenter analysis. Eur J Cardiothorac Surg. 2024;67(1):ezae414. doi:10.1093/ejcts/ezae414.

Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic.


See Avalus™ Bioprosthesis risk information: https://www.medtronic.com/en-us/healthcare-professionals/products/cardiovascular/heart-valves/tissue-valves-conduits/avalus-bioprosthesis.html?sheet=open 

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Valve Replacement After Prior Transcatheter Aortic Valve Replacement (Segment 3) 44 44 Valve Replacement After Prior Transcatheter Aortic Valve Replacement (Segment 3) full f671f9c4-6ae5-48bb-889e-8dbcd6702c48 https://share.transistor.fm/s/70f81989 Listen as Professor Pieter Kappetein discusses redo surgical aortic valve replacement after prior transcatheter aortic valve replacement (TAVR) surgery and considerations from lifetime management with Dr. Stanley Chetcuti, Dr. Robert Hawkins and Dr. Himanshu Jagdish Patel from the Frankel Cardiovascular Center at the University of Michigan. Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic. 

Segment 3 focuses on discussing guidelines and advantages of trails

]]> Listen as Professor Pieter Kappetein discusses redo surgical aortic valve replacement after prior transcatheter aortic valve replacement (TAVR) surgery and considerations from lifetime management with Dr. Stanley Chetcuti, Dr. Robert Hawkins and Dr. Himanshu Jagdish Patel from the Frankel Cardiovascular Center at the University of Michigan. Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic. 

Segment 3 focuses on discussing guidelines and advantages of trails

]]> Thu, 17 Apr 2025 13:35:08 -0500 Medtronic Medtronic 734 Listen as Professor Pieter Kappetein discusses redo surgical aortic valve replacement after prior transcatheter aortic valve replacement (TAVR) surgery and considerations from lifetime management with Dr. Stanley Chetcuti, Dr. Robert Hawkins and Dr. Himanshu Jagdish Patel from the Frankel Cardiovascular Center at the University of Michigan. Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic. 

Segment 3 focuses on discussing guidelines and advantages of trails

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Valve Replacement After Prior Transcatheter Aortic Valve Replacement (Segment 2) 43 43 Valve Replacement After Prior Transcatheter Aortic Valve Replacement (Segment 2) full e9738713-6eea-4445-9aae-a144f96b915f https://share.transistor.fm/s/92c12e52 Listen as Professor Pieter Kappetein discusses redo surgical aortic valve replacement after prior transcatheter aortic valve replacement (TAVR) surgery and considerations from lifetime management with Dr. Stanley Chetcuti, Dr. Robert Hawkins and Dr. Himanshu Jagdish Patel from the Frankel Cardiovascular Center at the University of Michigan. Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic. 

Segment 2 focuses on patient factors, best practices and strategies and valve size

]]> Listen as Professor Pieter Kappetein discusses redo surgical aortic valve replacement after prior transcatheter aortic valve replacement (TAVR) surgery and considerations from lifetime management with Dr. Stanley Chetcuti, Dr. Robert Hawkins and Dr. Himanshu Jagdish Patel from the Frankel Cardiovascular Center at the University of Michigan. Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic. 

Segment 2 focuses on patient factors, best practices and strategies and valve size

]]> Thu, 17 Apr 2025 13:34:05 -0500 Medtronic Medtronic 1361 Listen as Professor Pieter Kappetein discusses redo surgical aortic valve replacement after prior transcatheter aortic valve replacement (TAVR) surgery and considerations from lifetime management with Dr. Stanley Chetcuti, Dr. Robert Hawkins and Dr. Himanshu Jagdish Patel from the Frankel Cardiovascular Center at the University of Michigan. Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic. 

Segment 2 focuses on patient factors, best practices and strategies and valve size

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Valve Replacement After Prior Transcatheter Aortic Valve Replacement (Segment 1) 42 42 Valve Replacement After Prior Transcatheter Aortic Valve Replacement (Segment 1) full 613d261b-446a-4910-9470-40c8ec94c724 https://share.transistor.fm/s/5f9aa552 Listen as Professor Pieter Kappetein discusses redo surgical aortic valve replacement after prior transcatheter aortic valve replacement (TAVR) surgery and considerations from lifetime management with Dr. Stanley Chetcuti, Dr. Robert Hawkins and Dr. Himanshu Jagdish Patel from the Frankel Cardiovascular Center at the University of Michigan. Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic. 

Segment 1 focuses on growing popularity and lifetime management and risks

]]> Listen as Professor Pieter Kappetein discusses redo surgical aortic valve replacement after prior transcatheter aortic valve replacement (TAVR) surgery and considerations from lifetime management with Dr. Stanley Chetcuti, Dr. Robert Hawkins and Dr. Himanshu Jagdish Patel from the Frankel Cardiovascular Center at the University of Michigan. Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic. 

Segment 1 focuses on growing popularity and lifetime management and risks

]]> Thu, 17 Apr 2025 13:31:07 -0500 Medtronic Medtronic 991 Listen as Professor Pieter Kappetein discusses redo surgical aortic valve replacement after prior transcatheter aortic valve replacement (TAVR) surgery and considerations from lifetime management with Dr. Stanley Chetcuti, Dr. Robert Hawkins and Dr. Himanshu Jagdish Patel from the Frankel Cardiovascular Center at the University of Michigan. Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic. 

Segment 1 focuses on growing popularity and lifetime management and risks

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Penditure Exclusion System: Left Atrial Appendage Management (Segment 2) 41 41 Penditure Exclusion System: Left Atrial Appendage Management (Segment 2) full 9a6383b3-a291-4dfb-b73e-c74c07a14d7a https://share.transistor.fm/s/f06fd880 Penditure Exclusion System: Left Atrial Appendage Management

Host: Pieter Kappetein

Guests: Dr. Robert Hawkins – Frankel Cardiovascular Center, University of Michigan, Dr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia 


Segment 2: Robotic Closure, Appendage management for all AFib patients

]]> Penditure Exclusion System: Left Atrial Appendage Management

Host: Pieter Kappetein

Guests: Dr. Robert Hawkins – Frankel Cardiovascular Center, University of Michigan, Dr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia 


Segment 2: Robotic Closure, Appendage management for all AFib patients

]]> Wed, 14 Aug 2024 10:18:03 -0500 Medtronic Medtronic 1110 Penditure Exclusion System: Left Atrial Appendage Management

Host: Pieter Kappetein

Guests: Dr. Robert Hawkins – Frankel Cardiovascular Center, University of Michigan, Dr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia 


Segment 2: Robotic Closure, Appendage management for all AFib patients

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Penditure Exclusion System: Left Atrial Appendage Management (Segment 1) 40 40 Penditure Exclusion System: Left Atrial Appendage Management (Segment 1) full f3d309bc-f477-4812-8b2e-8f318052e99b https://share.transistor.fm/s/81bb2287 Penditure Exclusion System: Left Atrial Appendage Management

Host: Pieter Kappetein

Guests: Dr. Robert Hawkins – Frankel Cardiovascular Center, University of Michigan, Dr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia 

Segment 1: Candidates, Circumstances, Clip Placement

]]> Penditure Exclusion System: Left Atrial Appendage Management

Host: Pieter Kappetein

Guests: Dr. Robert Hawkins – Frankel Cardiovascular Center, University of Michigan, Dr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia 

Segment 1: Candidates, Circumstances, Clip Placement

]]> Wed, 14 Aug 2024 10:16:59 -0500 Medtronic Medtronic 1232 Penditure Exclusion System: Left Atrial Appendage Management

Host: Pieter Kappetein

Guests: Dr. Robert Hawkins – Frankel Cardiovascular Center, University of Michigan, Dr. Gianluca Torregrossa – Lankenau Medical Center, Philadelphia 

Segment 1: Candidates, Circumstances, Clip Placement

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Left Atrial Appendage Management (Segment 3) 39 39 Left Atrial Appendage Management (Segment 3) full 044bd704-4366-49e0-b62f-9f48562a12b8 https://share.transistor.fm/s/1fb9c227 Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.

]]> Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.

]]> Mon, 26 Feb 2024 09:47:56 -0600 Medtronic Medtronic 769 Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Left Atrial Appendage Management (Segment 2) 38 38 Left Atrial Appendage Management (Segment 2) full 117c476f-2699-4fb5-81ee-8f2df56d4972 https://share.transistor.fm/s/d82e4ff8 Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.

]]> Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.

]]> Mon, 26 Feb 2024 09:47:48 -0600 Medtronic Medtronic 854 Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Left Atrial Appendage Management (Segment 1) 37 37 Left Atrial Appendage Management (Segment 1) full 55941dae-23cd-465a-a3a5-a87bd8e9f048 https://share.transistor.fm/s/a7a08467 Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.

]]> Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.

]]> Mon, 26 Feb 2024 09:47:39 -0600 Medtronic Medtronic 965 Listen as Professor Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine , Dr. Basel Ramlawi of Lankenau Heart Institute and Dr. Gregory Rushing of University Hospitals.

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Anticoagulation of stented valves - What does the future hold (Segment 4) 36 36 Anticoagulation of stented valves - What does the future hold (Segment 4) full d412d992-16ab-46f9-956f-298dd9d32562 https://share.transistor.fm/s/069ff777 Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

]]> Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

]]> Mon, 18 Sep 2023 09:54:00 -0500 Medtronic Medtronic 553 Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Anticoagulation of stented valves - Strategies based on patient age (Segment 3) 35 35 Anticoagulation of stented valves - Strategies based on patient age (Segment 3) full 57d6b543-f368-426c-9ed7-55bb6951f9b1 https://share.transistor.fm/s/ddc0a04a Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

]]> Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

]]> Mon, 18 Sep 2023 09:53:49 -0500 Medtronic Medtronic 576 Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Anticoagulation of stented valves - Medication options (Segment 2) 34 34 Anticoagulation of stented valves - Medication options (Segment 2) full 3fc35db7-8e40-4fd0-b817-1aa44475b935 https://share.transistor.fm/s/ca0bb920 Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

]]> Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

]]> Mon, 18 Sep 2023 09:52:07 -0500 Medtronic Medtronic 739 Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Anticoagulation of stented valves - Anticoagulation guideline compliance (Segment 1) 33 33 Anticoagulation of stented valves - Anticoagulation guideline compliance (Segment 1) full d81d1712-513e-4fdb-af05-dfc8e9ea6a62 https://share.transistor.fm/s/e3b775a7 Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

]]> Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

]]> Mon, 18 Sep 2023 09:51:51 -0500 Medtronic Medtronic 751 Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women's Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No SAVR vs TAVR - Bicuspid, endocarditis and anticoagulation 32 32 SAVR vs TAVR - Bicuspid, endocarditis and anticoagulation full abb855c1-040d-4085-a22d-7faf20c9e1b0 https://share.transistor.fm/s/d592813a Cardiac surgeons Dr. Michael Reardon from Houston Methodist and Dr. Bradley Leshnower from Emory University with interventional cardiologist Dr. Sachin Goel from Houston Methodist discuss SAVR versus TAVR. Topics include: which patients benefit from SAVR procedures, considerations for optimizing SAVR via root enlargement, and lifetime patient management as it relates to SAVR versus TAVR procedures.

]]> Cardiac surgeons Dr. Michael Reardon from Houston Methodist and Dr. Bradley Leshnower from Emory University with interventional cardiologist Dr. Sachin Goel from Houston Methodist discuss SAVR versus TAVR. Topics include: which patients benefit from SAVR procedures, considerations for optimizing SAVR via root enlargement, and lifetime patient management as it relates to SAVR versus TAVR procedures.

]]> Tue, 08 Aug 2023 15:14:52 -0500 Medtronic Medtronic 928 Cardiac surgeons Dr. Michael Reardon from Houston Methodist and Dr. Bradley Leshnower from Emory University with interventional cardiologist Dr. Sachin Goel from Houston Methodist discuss SAVR versus TAVR. Topics include: which patients benefit from SAVR procedures, considerations for optimizing SAVR via root enlargement, and lifetime patient management as it relates to SAVR versus TAVR procedures.

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No SAVR vs TAVR - Lifetime management and considerations 31 31 SAVR vs TAVR - Lifetime management and considerations full 633da964-e24e-4b44-a9dc-4fabab84717e https://share.transistor.fm/s/8eeee54a Cardiac surgeons Dr. Michael Reardon from Houston Methodist and Dr. Bradley Leshnower from Emory University with interventional cardiologist Dr. Sachin Goel from Houston Methodist discuss SAVR versus TAVR. Topics include: which patients benefit from SAVR procedures, considerations for optimizing SAVR via root enlargement, and lifetime patient management as it relates to SAVR versus TAVR procedures.

]]> Cardiac surgeons Dr. Michael Reardon from Houston Methodist and Dr. Bradley Leshnower from Emory University with interventional cardiologist Dr. Sachin Goel from Houston Methodist discuss SAVR versus TAVR. Topics include: which patients benefit from SAVR procedures, considerations for optimizing SAVR via root enlargement, and lifetime patient management as it relates to SAVR versus TAVR procedures.

]]> Tue, 08 Aug 2023 15:13:21 -0500 Medtronic Medtronic 912 Cardiac surgeons Dr. Michael Reardon from Houston Methodist and Dr. Bradley Leshnower from Emory University with interventional cardiologist Dr. Sachin Goel from Houston Methodist discuss SAVR versus TAVR. Topics include: which patients benefit from SAVR procedures, considerations for optimizing SAVR via root enlargement, and lifetime patient management as it relates to SAVR versus TAVR procedures.

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No The next generation - Learning, training, and technology (Segment 3) 30 30 The next generation - Learning, training, and technology (Segment 3) full aa4f1730-d3e2-4bf4-a0d1-fa601d623f2d https://share.transistor.fm/s/ec6d5ce2 Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery residents and fellows for a candid chat. James Bailey, M.D., Tessa Watt, M.D., Daniel Ziazadeh, M.D., and Natalie Ostro, M.D. talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.

]]> Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery residents and fellows for a candid chat. James Bailey, M.D., Tessa Watt, M.D., Daniel Ziazadeh, M.D., and Natalie Ostro, M.D. talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.

]]> Mon, 10 Apr 2023 14:49:46 -0500 Medtronic Medtronic 1071 Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery residents and fellows for a candid chat. James Bailey, M.D., Tessa Watt, M.D., Daniel Ziazadeh, M.D., and Natalie Ostro, M.D. talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No The next generation - Gender diversity and work/life balance (Segment 2) 29 29 The next generation - Gender diversity and work/life balance (Segment 2) full bcd54461-16aa-4ab4-a98a-68a7875f555b https://share.transistor.fm/s/155454ce Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery residents and fellows for a candid chat. James Bailey, M.D., Tessa Watt, M.D., Daniel Ziazadeh, M.D., and Natalie Ostro, M.D. talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.

]]> Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery residents and fellows for a candid chat. James Bailey, M.D., Tessa Watt, M.D., Daniel Ziazadeh, M.D., and Natalie Ostro, M.D. talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.

]]> Mon, 10 Apr 2023 14:48:20 -0500 Medtronic Medtronic 866 Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery residents and fellows for a candid chat. James Bailey, M.D., Tessa Watt, M.D., Daniel Ziazadeh, M.D., and Natalie Ostro, M.D. talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No The next generation - Residency (Segment 1) 28 28 The next generation - Residency (Segment 1) full c51d4cee-66fd-4eba-9859-0603e496d93d https://share.transistor.fm/s/e35d8b87 Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery residents and fellows for a candid chat. James Bailey, M.D., Tessa Watt, M.D., Daniel Ziazadeh, M.D., and Natalie Ostro, M.D. talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.

]]> Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery residents and fellows for a candid chat. James Bailey, M.D., Tessa Watt, M.D., Daniel Ziazadeh, M.D., and Natalie Ostro, M.D. talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.

]]> Mon, 10 Apr 2023 14:46:41 -0500 Medtronic Medtronic 1081 Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four Cardiac Surgery residents and fellows for a candid chat. James Bailey, M.D., Tessa Watt, M.D., Daniel Ziazadeh, M.D., and Natalie Ostro, M.D. talk about their start in Cardiac Surgery, current challenges, workplace dynamics, and the future of the of the specialty.

]]> Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No STS 2022 Highlights (Segment 4) 27 27 STS 2022 Highlights (Segment 4) full 12926631-9b45-4d59-9f6d-565e143e202f https://share.transistor.fm/s/838044e3 Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF.

]]> Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF.

]]> Wed, 31 Aug 2022 13:14:57 -0500 Medtronic Medtronic 1054 Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF. Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the Uni Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No STS 2022 Highlights (Segment 3) 26 26 STS 2022 Highlights (Segment 3) full 2d555535-b271-4cc6-8521-c54e91b4587d https://share.transistor.fm/s/0e1de908 Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF.

]]> Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF.

]]> Wed, 31 Aug 2022 13:13:07 -0500 Medtronic Medtronic 623 Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF. Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the Uni Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No STS 2022 Highlights (Segment 2) 25 25 STS 2022 Highlights (Segment 2) full c8180445-00a5-41ec-a26a-efdac4e92a0d https://share.transistor.fm/s/9719724a Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF.

]]> Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF.

]]> Wed, 31 Aug 2022 13:11:27 -0500 Medtronic Medtronic 985 Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF. Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the Uni Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No STS 2022 Highlights (Segment 1) 24 24 STS 2022 Highlights (Segment 1) full e99e964a-5bdd-4b1f-b8be-dc158bb18a6e https://share.transistor.fm/s/f3cd0cde Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF.

]]> Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF.

]]> Wed, 31 Aug 2022 13:09:54 -0500 Medtronic Medtronic 1159 Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc of the University of British Columbia and Dr. Tom Nguyen from UCSF. Highlights from STS – Don't miss the discussions in which Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the Uni Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Evolution of ECMO (Segment 3) 23 23 Evolution of ECMO (Segment 3) full e7850e2f-81b0-4b82-ac4f-540edbca7a90 https://share.transistor.fm/s/f21fd72a Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving life-saving ECMO changes today. Dr. Bartlett also shares his perspective on the key success factors for those interested in starting an ECMO program.


]]> Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving life-saving ECMO changes today. Dr. Bartlett also shares his perspective on the key success factors for those interested in starting an ECMO program.


]]> Wed, 10 Aug 2022 10:09:27 -0500 Medtronic Medtronic 1139 Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving life-saving ECMO changes today. Dr. Bartlett also shares his perspective on the key success factors for those interested in starting an ECMO program. Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO, Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Evolution of ECMO (Segment 2) 22 22 Evolution of ECMO (Segment 2) full 69139eee-f6f6-4a1d-9f2d-5916f9a11115 https://share.transistor.fm/s/854d838a Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving life-saving ECMO changes today. Dr. Bartlett also shares his perspective on the key success factors for those interested in starting an ECMO program.


]]> Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving life-saving ECMO changes today. Dr. Bartlett also shares his perspective on the key success factors for those interested in starting an ECMO program.


]]> Wed, 10 Aug 2022 10:06:06 -0500 Medtronic Medtronic 1290 Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving life-saving ECMO changes today. Dr. Bartlett also shares his perspective on the key success factors for those interested in starting an ECMO program. Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO, Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Evolution of ECMO (Segment 1) 21 21 Evolution of ECMO (Segment 1) full 2e82add1-dd3e-4ccc-aa00-e58b1826b7c7 https://share.transistor.fm/s/a904245e Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving life-saving ECMO changes today. Dr. Bartlett also shares his perspective on the key success factors for those interested in starting an ECMO program.


]]> Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving life-saving ECMO changes today. Dr. Bartlett also shares his perspective on the key success factors for those interested in starting an ECMO program.


]]> Wed, 10 Aug 2022 09:57:30 -0500 Medtronic Medtronic 1097 Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving life-saving ECMO changes today. Dr. Bartlett also shares his perspective on the key success factors for those interested in starting an ECMO program. Life-saving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO, Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No ACC/AHA Coronary Revascularization Guidelines (Segment 2) 20 20 ACC/AHA Coronary Revascularization Guidelines (Segment 2) full f4fcd350-f3f3-4920-9deb-21d6cd01c228 https://share.transistor.fm/s/da1ed1ca A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with 3-vessel disease and normal LV function.  The panel provides a rebuttal on the benefits of CABG vs medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions.

]]> A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with 3-vessel disease and normal LV function.  The panel provides a rebuttal on the benefits of CABG vs medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions.

]]> Mon, 25 Apr 2022 15:42:25 -0500 Medtronic Medtronic 1280 A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with 3-vessel disease and normal LV function. The panel provides a rebuttal on the benefits of CABG vs medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions. A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with 3-vessel disease and normal LV function. The panel provides a rebuttal on the benefits of CABG vs medical t Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No ACC/AHA Coronary Revascularization Guidelines (Segment 1) 19 19 ACC/AHA Coronary Revascularization Guidelines (Segment 1) full 41f17617-621d-46f0-8c75-ca193e4fb273 https://share.transistor.fm/s/c292cdfa A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with 3-vessel disease and normal LV function.  The panel provides a rebuttal on the benefits of CABG vs medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions.

]]> A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with 3-vessel disease and normal LV function.  The panel provides a rebuttal on the benefits of CABG vs medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions.

]]> Mon, 25 Apr 2022 15:42:14 -0500 Medtronic Medtronic 1133 A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with 3-vessel disease and normal LV function. The panel provides a rebuttal on the benefits of CABG vs medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions. A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with 3-vessel disease and normal LV function. The panel provides a rebuttal on the benefits of CABG vs medical t Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Recent Happening and Trends in Mitral Valve Repair (Segment 4) 18 18 Recent Happening and Trends in Mitral Valve Repair (Segment 4) full 4ec098ea-59f7-46d3-9e54-da0653da01f1 https://share.transistor.fm/s/de6d3ebd In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team.

]]> In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team.

]]> Wed, 20 Apr 2022 15:43:54 -0500 Medtronic Medtronic 691 In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team. In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington U Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Recent Happening and Trends in Mitral Valve Repair (Segment 3) 17 17 Recent Happening and Trends in Mitral Valve Repair (Segment 3) full 5f3476ba-8ce2-4530-ba7e-78b216c634d1 https://share.transistor.fm/s/a21d4057 In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team.

]]> In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team.

]]> Wed, 20 Apr 2022 15:40:57 -0500 Medtronic Medtronic 740 In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team. In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington U Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Recent Happening and Trends in Mitral Valve Repair (Segment 2) 16 16 Recent Happening and Trends in Mitral Valve Repair (Segment 2) full 7bd030d7-75b2-415a-99b9-1df8b9bcba12 https://share.transistor.fm/s/57c8df25 In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team.

]]> In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team.

]]> Wed, 20 Apr 2022 15:36:37 -0500 Medtronic Medtronic 1022 In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team. In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington U Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Recent Happening and Trends in Mitral Valve Repair (Segment 1) 15 15 Recent Happening and Trends in Mitral Valve Repair (Segment 1) full a8d2950f-7193-4883-ab4a-9e34a5a77368 https://share.transistor.fm/s/a84952fb In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team.

]]> In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team.

]]> Wed, 20 Apr 2022 15:33:29 -0500 Medtronic Medtronic 983 In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical steps to set up a Robotics program and the importance of the Mitral Heart Team. In this series Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington U Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No 2021 EACTS Discussion (Segment 2) 14 14 2021 EACTS Discussion (Segment 2) full f723e272-c7df-466b-a747-3dc9a89a08ba https://share.transistor.fm/s/5337f2a3 Listen in to hear Professor Pieter Kappetein, Chief Medical Officer, Vice President, Cardiac Surgery at Medtronic, Professor Bart Meuris of UZ Leuven in Belgium and Professor Martin Andreas of the Medical University of Vienna discuss highlights from the 2021 EACTS annual conference.

]]> Listen in to hear Professor Pieter Kappetein, Chief Medical Officer, Vice President, Cardiac Surgery at Medtronic, Professor Bart Meuris of UZ Leuven in Belgium and Professor Martin Andreas of the Medical University of Vienna discuss highlights from the 2021 EACTS annual conference.

]]> Tue, 12 Apr 2022 12:34:22 -0500 Medtronic Medtronic 1177 Listen in to hear Professor Pieter Kappetein, Chief Medical Officer, Vice President, Cardiac Surgery at Medtronic, Professor Bart Meuris of UZ Leuven in Belgium and Professor Martin Andreas of the Medical University of Vienna discuss highlights from the 2021 EACTS annual conference. Listen in to hear Professor Pieter Kappetein, Chief Medical Officer, Vice President, Cardiac Surgery at Medtronic, Professor Bart Meuris of UZ Leuven in Belgium and Professor Martin Andreas of the Medical University of Vienna discuss highlights from the 2 Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No 2021 EACTS Discussion (Segment 1) 13 13 2021 EACTS Discussion (Segment 1) full 2c069d08-38ab-42b1-976f-bbe1e8b7bf7d https://share.transistor.fm/s/bbfc7cde Listen in to hear Professor Pieter Kappetein, Chief Medical Officer, Vice President, Cardiac Surgery at Medtronic, Professor Bart Meuris of UZ Leuven in Belgium and Professor Martin Andreas of the Medical University of Vienna discuss highlights from the 2021 EACTS annual conference.

]]> Listen in to hear Professor Pieter Kappetein, Chief Medical Officer, Vice President, Cardiac Surgery at Medtronic, Professor Bart Meuris of UZ Leuven in Belgium and Professor Martin Andreas of the Medical University of Vienna discuss highlights from the 2021 EACTS annual conference.

]]> Tue, 12 Apr 2022 12:32:35 -0500 Medtronic Medtronic 974 Listen in to hear Professor Pieter Kappetein, Chief Medical Officer, Vice President, Cardiac Surgery at Medtronic, Professor Bart Meuris of UZ Leuven in Belgium and Professor Martin Andreas of the Medical University of Vienna discuss highlights from the 2021 EACTS annual conference. Listen in to hear Professor Pieter Kappetein, Chief Medical Officer, Vice President, Cardiac Surgery at Medtronic, Professor Bart Meuris of UZ Leuven in Belgium and Professor Martin Andreas of the Medical University of Vienna discuss highlights from the 2 Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Lifetime Management of SAVR Patients (Segment 3) 12 12 Lifetime Management of SAVR Patients (Segment 3) full f060331e-9d43-427d-b74f-5783b54f86b4 https://share.transistor.fm/s/db790a9f Tue, 23 Nov 2021 14:19:37 -0600 Medtronic Medtronic 1665 There are many options for the treatment for aortic valve disease. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Joseph Bavaria from the Hospital of the University of Pennsylvania, Dr. Bob Kiaii from UC Davis Medical Center and Dr. Maral Ouzounian from the Toronto General Hospital as they discuss the lifetime management of surgical aortic valve replacement patients. There are many options for the treatment for aortic valve disease. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Joseph Bavaria from the Hospital of the University of Pennsylvania Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Lifetime Management of SAVR Patients (Segment 2) 11 11 Lifetime Management of SAVR Patients (Segment 2) full 3c4a0e43-55e3-4c04-aea1-4cfa4cf34d6a https://share.transistor.fm/s/a24225e9 Tue, 23 Nov 2021 14:16:48 -0600 Medtronic Medtronic 1187 There are many options for the treatment for aortic valve disease. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Joseph Bavaria from the Hospital of the University of Pennsylvania, Dr. Bob Kiaii from UC Davis Medical Center and Dr. Maral Ouzounian from the Toronto General Hospital as they discuss the lifetime management of surgical aortic valve replacement patients. There are many options for the treatment for aortic valve disease. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Joseph Bavaria from the Hospital of the University of Pennsylvania Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Lifetime Management of SAVR Patients (Segment 1) 10 10 Lifetime Management of SAVR Patients (Segment 1) full 669f8e34-4d5c-44fb-b5d0-7bd74cd057aa https://share.transistor.fm/s/e3595b69 Tue, 23 Nov 2021 14:14:33 -0600 Medtronic Medtronic 758 There are many options for the treatment for aortic valve disease. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Joseph Bavaria from the Hospital of the University of Pennsylvania, Dr. Bob Kiaii from UC Davis Medical Center and Dr. Maral Ouzounian from the Toronto General Hospital as they discuss the lifetime management of surgical aortic valve replacement patients. There are many options for the treatment for aortic valve disease. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Joseph Bavaria from the Hospital of the University of Pennsylvania Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Current and Future State of Coronary Surgery (Segment 3) 9 9 Current and Future State of Coronary Surgery (Segment 3) full 892e5824-0222-4045-a326-5b640e3a53f4 https://share.transistor.fm/s/15df7227 Tue, 02 Nov 2021 15:44:03 -0500 Medtronic Medtronic 857 Tune in for an in-depth discussion on the current and future state of coronary surgery. This series is led by Professor Pieter Kappetein, who is joined by Dr. Marc Ruel of the Ottawa Heart Institute, Dr. John Puskas from Mount Sinai Morningside in New York, and Dr. Teresa Kieser from the University of Calgary. Together, they will provide insights into the progress, current trends, and the future of coronary surgery — covering topics that include the role of total arterial revascularization, minimally invasive approaches, and learning outside of the fellowship. Tune in for an in-depth discussion on the current and future state of coronary surgery. This series is led by Professor Pieter Kappetein, who is joined by Dr. Marc Ruel of the Ottawa Heart Institute, Dr. John Puskas from Mount Sinai Morningside in New Yor Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Current and Future State of Coronary Surgery (Segment 2) 8 8 Current and Future State of Coronary Surgery (Segment 2) full 379b7dc0-6e9d-4cf2-949d-9ef9ceb4edb9 https://share.transistor.fm/s/95491072 Tue, 02 Nov 2021 15:42:14 -0500 Medtronic Medtronic 1358 Tune in for an in-depth discussion on the current and future state of coronary surgery. This series is led by Professor Pieter Kappetein, who is joined by Dr. Marc Ruel of the Ottawa Heart Institute, Dr. John Puskas from Mount Sinai Morningside in New York, and Dr. Teresa Kieser from the University of Calgary. Together, they will provide insights into the progress, current trends, and the future of coronary surgery — covering topics that include the role of total arterial revascularization, minimally invasive approaches, and learning outside of the fellowship. Tune in for an in-depth discussion on the current and future state of coronary surgery. This series is led by Professor Pieter Kappetein, who is joined by Dr. Marc Ruel of the Ottawa Heart Institute, Dr. John Puskas from Mount Sinai Morningside in New Yor Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Current and Future State of Coronary Surgery (Segment 1) 7 7 Current and Future State of Coronary Surgery (Segment 1) full cdeaaa21-3373-431c-8edb-1a8da325fcdd https://share.transistor.fm/s/26be8dd4 Tue, 02 Nov 2021 15:39:29 -0500 Medtronic Medtronic 1170 Tune in for an in-depth discussion on the current and future state of coronary surgery. This series is led by Professor Pieter Kappetein, who is joined by Dr. Marc Ruel of the Ottawa Heart Institute, Dr. John Puskas from Mount Sinai Morningside in New York, and Dr. Teresa Kieser from the University of Calgary. Together, they will provide insights into the progress, current trends, and the future of coronary surgery — covering topics that include the role of total arterial revascularization, minimally invasive approaches, and learning outside of the fellowship. Tune in for an in-depth discussion on the current and future state of coronary surgery. This series is led by Professor Pieter Kappetein, who is joined by Dr. Marc Ruel of the Ottawa Heart Institute, Dr. John Puskas from Mount Sinai Morningside in New Yor Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Diversity in Healthcare (Segment 3) 6 6 Diversity in Healthcare (Segment 3) full bb1616ee-5f54-4ed6-b93a-4d904700e42b https://share.transistor.fm/s/56bfd1cb Mon, 20 Sep 2021 21:46:33 -0500 Medtronic Medtronic 1666 Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss the importance of diversity in healthcare. Hear what their institutions are doing to achieve it and the challenges they are overcoming along the way. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss th Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Diversity in Healthcare (Segment 2) 5 5 Diversity in Healthcare (Segment 2) full 83f2606c-cf69-4469-af82-27aaf6c75cb4 https://share.transistor.fm/s/10fd95b9 Mon, 20 Sep 2021 21:44:30 -0500 Medtronic Medtronic 743 Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss the importance of diversity in healthcare. Hear what their institutions are doing to achieve it and the challenges they are overcoming along the way. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss th Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No Diversity in Healthcare (Segment 1) 4 4 Diversity in Healthcare (Segment 1) full 05d3539b-b35e-4439-8fa1-d8ed13acdfd4 https://share.transistor.fm/s/585fdb09 Mon, 20 Sep 2021 21:42:50 -0500 Medtronic Medtronic 877 Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss the importance of diversity in healthcare. Hear what their institutions are doing to achieve it and the challenges they are overcoming along the way. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss th Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No COVID and Cardiac Surgery – Where are we now? (Segment 3) 3 3 COVID and Cardiac Surgery – Where are we now? (Segment 3) full 0922b92c-674f-42df-a80f-9ff83bc20763 https://share.transistor.fm/s/5b26bc3d Mon, 16 Aug 2021 08:46:17 -0500 Medtronic Medtronic 969 The COVID-19 pandemic has made a significant impact on Cardiac surgery. Listen in as Dr. Pieter Kappetein, Dr. Eugene Grossi of NYU and Dr. Kendra Grubb of Emory discuss how COVID-19 has affected their patients, practice, and how their institutions are moving forward. The COVID-19 pandemic has made a significant impact on Cardiac surgery. Listen in as Dr. Pieter Kappetein, Dr. Eugene Grossi of NYU and Dr. Kendra Grubb of Emory discuss how COVID-19 has affected their patients, practice, and how their institutions are mo Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No COVID and Cardiac Surgery – Where are we now? (Segment 2) 2 2 COVID and Cardiac Surgery – Where are we now? (Segment 2) full 1e136919-75b8-4514-980b-055622354fe2 https://share.transistor.fm/s/28aa4329 Mon, 16 Aug 2021 08:42:57 -0500 Medtronic Medtronic 978 The COVID-19 pandemic has made a significant impact on Cardiac surgery. Listen in as Dr. Pieter Kappetein, Dr. Eugene Grossi of NYU and Dr. Kendra Grubb of Emory discuss how COVID-19 has affected their patients, practice, and how their institutions are moving forward. The COVID-19 pandemic has made a significant impact on Cardiac surgery. Listen in as Dr. Pieter Kappetein, Dr. Eugene Grossi of NYU and Dr. Kendra Grubb of Emory discuss how COVID-19 has affected their patients, practice, and how their institutions are mo Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No COVID and Cardiac Surgery – Where are we now? (Segment 1) 1 1 COVID and Cardiac Surgery – Where are we now? (Segment 1) full 9f166fb5-823c-4575-8aef-7c3ed6eb7699 https://share.transistor.fm/s/276b849e Thu, 12 Aug 2021 09:37:08 -0500 Medtronic Medtronic 1192 The COVID-19 pandemic has made a significant impact on Cardiac surgery. Listen in as Dr. Pieter Kappetein, Dr. Eugene Grossi of NYU and Dr. Kendra Grubb of Emory discuss how COVID-19 has affected their patients, practice, and how their institutions are moving forward. The COVID-19 pandemic has made a significant impact on Cardiac surgery. Listen in as Dr. Pieter Kappetein, Dr. Eugene Grossi of NYU and Dr. Kendra Grubb of Emory discuss how COVID-19 has affected their patients, practice, and how their institutions are mo Medtronic, Cardiac Surgery, COVID, Medical Device, Healthcare, Surgery No